Using dual ISH-IF analysis of mouse and human lung cancer sections, we revealed that tumor cells as well as tumor-infiltrating immune cells, such as CD8+ T, NK cells, and macrophages express CB2 at much higher levels than CB1. This evidence concerns the gene CD8A and lung carcinoma.